Impact of Facility-Based Mother Support Groups on Retention in Care and PMTCT Outcomes in Rural Zimbabwe: The EPAZ Cluster-Randomized Controlled Trial.
Identifieur interne : 000C05 ( Main/Exploration ); précédent : 000C04; suivant : 000C06Impact of Facility-Based Mother Support Groups on Retention in Care and PMTCT Outcomes in Rural Zimbabwe: The EPAZ Cluster-Randomized Controlled Trial.
Auteurs : Geoff Foster [Zimbabwe] ; Joanna Orne-Gliemann ; Hélène Font ; Abigail Kangwende ; Vhumani Magezi ; Tonderai Sengai ; Simba Rusakaniko ; Bridget Shumba ; Pemberai Zambezi ; Talent MaphosaSource :
- Journal of acquired immune deficiency syndromes (1999) [ 1944-7884 ] ; 2017.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Agents antiVIH (usage thérapeutique), Analyse de regroupements (MeSH), Complications infectieuses de la grossesse (prévention et contrôle), Complications infectieuses de la grossesse (psychologie), Complications infectieuses de la grossesse (traitement médicamenteux), Femelle (MeSH), Grossesse (MeSH), Groupes d'entraide (MeSH), Humains (MeSH), Infections à VIH (psychologie), Infections à VIH (traitement médicamenteux), Infections à VIH (transmission), Jeune adulte (MeSH), Mères (MeSH), Nourrisson (MeSH), Nouveau-né (MeSH), Observance par le patient (psychologie), Observance par le patient (statistiques et données numériques), Population rurale (MeSH), Transmission verticale de maladie infectieuse (prévention et contrôle), Zimbabwe (épidémiologie), Évaluation de programme (MeSH).
- MESH :
- prévention et contrôle : Complications infectieuses de la grossesse, Transmission verticale de maladie infectieuse.
- psychologie : Complications infectieuses de la grossesse, Infections à VIH, Observance par le patient.
- statistiques et données numériques : Observance par le patient.
- traitement médicamenteux : Complications infectieuses de la grossesse, Infections à VIH.
- usage thérapeutique : Agents antiVIH, Infections à VIH.
- épidémiologie : Zimbabwe.
- Adolescent, Adulte, Analyse de regroupements, Femelle, Grossesse, Groupes d'entraide, Humains, Jeune adulte, Mères, Nourrisson, Nouveau-né, Population rurale, Évaluation de programme.
- Wicri :
- geographic : Zimbabwe.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Anti-HIV Agents (therapeutic use), Cluster Analysis (MeSH), Female (MeSH), HIV Infections (drug therapy), HIV Infections (psychology), HIV Infections (transmission), Humans (MeSH), Infant (MeSH), Infant, Newborn (MeSH), Infectious Disease Transmission, Vertical (prevention & control), Mothers (MeSH), Outcome Assessment, Health Care (MeSH), Patient Compliance (psychology), Patient Compliance (statistics & numerical data), Pregnancy (MeSH), Pregnancy Complications, Infectious (drug therapy), Pregnancy Complications, Infectious (prevention & control), Pregnancy Complications, Infectious (psychology), Program Evaluation (MeSH), Rural Population (MeSH), Self-Help Groups (MeSH), Young Adult (MeSH), Zimbabwe (epidemiology).
- MESH :
- chemical , therapeutic use : Anti-HIV Agents.
- geographic , epidemiology : Zimbabwe.
- drug therapy : HIV Infections, Pregnancy Complications, Infectious.
- prevention & control : Infectious Disease Transmission, Vertical, Pregnancy Complications, Infectious.
- psychology : HIV Infections, Patient Compliance, Pregnancy Complications, Infectious.
- statistics & numerical data : Patient Compliance.
- transmission : HIV Infections.
- Adolescent, Adult, Cluster Analysis, Female, Humans, Infant, Infant, Newborn, Mothers, Outcome Assessment, Health Care, Pregnancy, Program Evaluation, Rural Population, Self-Help Groups, Young Adult.
Abstract
BACKGROUND
Prevention of mother-to-child transmission elimination goals are hampered by low rates of retention in care. The Eliminating Paediatric AIDS in Zimbabwe project assessed whether mother support groups (MSGs) improve rates of retention in care of HIV-exposed infants and their HIV-positive mothers, and maternal and infant outcomes.
METHODS
The study involved 27 rural clinics in eastern Zimbabwe. MSGs were established in 14 randomly selected clinics and met every 2 weeks coordinated by volunteer HIV-positive mothers. MSG coordinators provided health education and reminded mothers of MSG meetings by cell phone. Infant retention in care was defined as "12 months postpartum point attendance" at health care visits of HIV-exposed infants at 12 months of age. We also measured regularity of attendance and other program indicators of HIV-positive mothers and their HIV-exposed infants.
RESULTS
Among 507 HIV-positive pregnant women assessed as eligible, 348 were enrolled and analyzed (69%) with mothers who had disclosed their HIV status being overrepresented. In the intervention arm, 69% of infants were retained in care at 12 months versus 61% in the control arm, with no statistically significant difference. Retention and other program outcomes were systematically higher in the intervention versus control arm, suggesting trends toward positive health outcomes with exposure to MSGs.
DISCUSSION
We were unable to show that facility-based MSGs improved retention in care at 12 months among HIV-exposed infants. Selective enrollment of mothers more likely to be retained-in-care may have contributed to lack of effect. Methods to increase the impact of MSGs on retention including targeting of high-risk mothers are discussed.
DOI: 10.1097/QAI.0000000000001360
PubMed: 28498191
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Impact of Facility-Based Mother Support Groups on Retention in Care and PMTCT Outcomes in Rural Zimbabwe: The EPAZ Cluster-Randomized Controlled Trial.</title><author><name sortKey="Foster, Geoff" sort="Foster, Geoff" uniqKey="Foster G" first="Geoff" last="Foster">Geoff Foster</name><affiliation wicri:level="4"><nlm:affiliation>*Ministry of Health and Child Care, Mutare, Zimbabwe; †Family AIDS Caring Trust, Mutare, Zimbabwe; ‡INSERM U1219-Centre Inserm Bordeaux Population Health, Université de Bordeaux, Bordeaux, France; §Université de Bordeaux, ISPED, Centre INSERM U1219-Bordeaux Population Health, Bordeaux, France; ‖Clinical Research Centre, Africa University, Mutare, Zimbabwe; ¶North West University, School of Basic Sciences, South Africa; #University of Zimbabwe, College of Health Sciences Harare, Zimbabwe; and **Organization for Public Health Interventions and Development, Harare, Zimbabwe.</nlm:affiliation><country xml:lang="fr">Zimbabwe</country><wicri:regionArea>*Ministry of Health and Child Care, Mutare, Zimbabwe; †Family AIDS Caring Trust, Mutare, Zimbabwe; ‡INSERM U1219-Centre Inserm Bordeaux Population Health, Université de Bordeaux, Bordeaux, France; §Université de Bordeaux, ISPED, Centre INSERM U1219-Bordeaux Population Health, Bordeaux, France; ‖Clinical Research Centre, Africa University, Mutare, Zimbabwe; ¶North West University, School of Basic Sciences, South Africa; #University of Zimbabwe, College of Health Sciences Harare, Zimbabwe; and **Organization for Public Health Interventions and Development, Harare</wicri:regionArea><orgName type="university">Université de Bordeaux</orgName><placeName><settlement type="city">Bordeaux</settlement><region type="region" nuts="2">Nouvelle-Aquitaine</region><region type="old region" nuts="2">Aquitaine</region></placeName></affiliation></author><author><name sortKey="Orne Gliemann, Joanna" sort="Orne Gliemann, Joanna" uniqKey="Orne Gliemann J" first="Joanna" last="Orne-Gliemann">Joanna Orne-Gliemann</name></author><author><name sortKey="Font, Helene" sort="Font, Helene" uniqKey="Font H" first="Hélène" last="Font">Hélène Font</name></author><author><name sortKey="Kangwende, Abigail" sort="Kangwende, Abigail" uniqKey="Kangwende A" first="Abigail" last="Kangwende">Abigail Kangwende</name></author><author><name sortKey="Magezi, Vhumani" sort="Magezi, Vhumani" uniqKey="Magezi V" first="Vhumani" last="Magezi">Vhumani Magezi</name></author><author><name sortKey="Sengai, Tonderai" sort="Sengai, Tonderai" uniqKey="Sengai T" first="Tonderai" last="Sengai">Tonderai Sengai</name></author><author><name sortKey="Rusakaniko, Simba" sort="Rusakaniko, Simba" uniqKey="Rusakaniko S" first="Simba" last="Rusakaniko">Simba Rusakaniko</name></author><author><name sortKey="Shumba, Bridget" sort="Shumba, Bridget" uniqKey="Shumba B" first="Bridget" last="Shumba">Bridget Shumba</name></author><author><name sortKey="Zambezi, Pemberai" sort="Zambezi, Pemberai" uniqKey="Zambezi P" first="Pemberai" last="Zambezi">Pemberai Zambezi</name></author><author><name sortKey="Maphosa, Talent" sort="Maphosa, Talent" uniqKey="Maphosa T" first="Talent" last="Maphosa">Talent Maphosa</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28498191</idno><idno type="pmid">28498191</idno><idno type="doi">10.1097/QAI.0000000000001360</idno><idno type="wicri:Area/Main/Corpus">000B57</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000B57</idno><idno type="wicri:Area/Main/Curation">000B57</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000B57</idno><idno type="wicri:Area/Main/Exploration">000B57</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Impact of Facility-Based Mother Support Groups on Retention in Care and PMTCT Outcomes in Rural Zimbabwe: The EPAZ Cluster-Randomized Controlled Trial.</title><author><name sortKey="Foster, Geoff" sort="Foster, Geoff" uniqKey="Foster G" first="Geoff" last="Foster">Geoff Foster</name><affiliation wicri:level="4"><nlm:affiliation>*Ministry of Health and Child Care, Mutare, Zimbabwe; †Family AIDS Caring Trust, Mutare, Zimbabwe; ‡INSERM U1219-Centre Inserm Bordeaux Population Health, Université de Bordeaux, Bordeaux, France; §Université de Bordeaux, ISPED, Centre INSERM U1219-Bordeaux Population Health, Bordeaux, France; ‖Clinical Research Centre, Africa University, Mutare, Zimbabwe; ¶North West University, School of Basic Sciences, South Africa; #University of Zimbabwe, College of Health Sciences Harare, Zimbabwe; and **Organization for Public Health Interventions and Development, Harare, Zimbabwe.</nlm:affiliation><country xml:lang="fr">Zimbabwe</country><wicri:regionArea>*Ministry of Health and Child Care, Mutare, Zimbabwe; †Family AIDS Caring Trust, Mutare, Zimbabwe; ‡INSERM U1219-Centre Inserm Bordeaux Population Health, Université de Bordeaux, Bordeaux, France; §Université de Bordeaux, ISPED, Centre INSERM U1219-Bordeaux Population Health, Bordeaux, France; ‖Clinical Research Centre, Africa University, Mutare, Zimbabwe; ¶North West University, School of Basic Sciences, South Africa; #University of Zimbabwe, College of Health Sciences Harare, Zimbabwe; and **Organization for Public Health Interventions and Development, Harare</wicri:regionArea><orgName type="university">Université de Bordeaux</orgName><placeName><settlement type="city">Bordeaux</settlement><region type="region" nuts="2">Nouvelle-Aquitaine</region><region type="old region" nuts="2">Aquitaine</region></placeName></affiliation></author><author><name sortKey="Orne Gliemann, Joanna" sort="Orne Gliemann, Joanna" uniqKey="Orne Gliemann J" first="Joanna" last="Orne-Gliemann">Joanna Orne-Gliemann</name></author><author><name sortKey="Font, Helene" sort="Font, Helene" uniqKey="Font H" first="Hélène" last="Font">Hélène Font</name></author><author><name sortKey="Kangwende, Abigail" sort="Kangwende, Abigail" uniqKey="Kangwende A" first="Abigail" last="Kangwende">Abigail Kangwende</name></author><author><name sortKey="Magezi, Vhumani" sort="Magezi, Vhumani" uniqKey="Magezi V" first="Vhumani" last="Magezi">Vhumani Magezi</name></author><author><name sortKey="Sengai, Tonderai" sort="Sengai, Tonderai" uniqKey="Sengai T" first="Tonderai" last="Sengai">Tonderai Sengai</name></author><author><name sortKey="Rusakaniko, Simba" sort="Rusakaniko, Simba" uniqKey="Rusakaniko S" first="Simba" last="Rusakaniko">Simba Rusakaniko</name></author><author><name sortKey="Shumba, Bridget" sort="Shumba, Bridget" uniqKey="Shumba B" first="Bridget" last="Shumba">Bridget Shumba</name></author><author><name sortKey="Zambezi, Pemberai" sort="Zambezi, Pemberai" uniqKey="Zambezi P" first="Pemberai" last="Zambezi">Pemberai Zambezi</name></author><author><name sortKey="Maphosa, Talent" sort="Maphosa, Talent" uniqKey="Maphosa T" first="Talent" last="Maphosa">Talent Maphosa</name></author></analytic><series><title level="j">Journal of acquired immune deficiency syndromes (1999)</title><idno type="eISSN">1944-7884</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Anti-HIV Agents (therapeutic use)</term><term>Cluster Analysis (MeSH)</term><term>Female (MeSH)</term><term>HIV Infections (drug therapy)</term><term>HIV Infections (psychology)</term><term>HIV Infections (transmission)</term><term>Humans (MeSH)</term><term>Infant (MeSH)</term><term>Infant, Newborn (MeSH)</term><term>Infectious Disease Transmission, Vertical (prevention & control)</term><term>Mothers (MeSH)</term><term>Outcome Assessment, Health Care (MeSH)</term><term>Patient Compliance (psychology)</term><term>Patient Compliance (statistics & numerical data)</term><term>Pregnancy (MeSH)</term><term>Pregnancy Complications, Infectious (drug therapy)</term><term>Pregnancy Complications, Infectious (prevention & control)</term><term>Pregnancy Complications, Infectious (psychology)</term><term>Program Evaluation (MeSH)</term><term>Rural Population (MeSH)</term><term>Self-Help Groups (MeSH)</term><term>Young Adult (MeSH)</term><term>Zimbabwe (epidemiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Agents antiVIH (usage thérapeutique)</term><term>Analyse de regroupements (MeSH)</term><term>Complications infectieuses de la grossesse (prévention et contrôle)</term><term>Complications infectieuses de la grossesse (psychologie)</term><term>Complications infectieuses de la grossesse (traitement médicamenteux)</term><term>Femelle (MeSH)</term><term>Grossesse (MeSH)</term><term>Groupes d'entraide (MeSH)</term><term>Humains (MeSH)</term><term>Infections à VIH (psychologie)</term><term>Infections à VIH (traitement médicamenteux)</term><term>Infections à VIH (transmission)</term><term>Jeune adulte (MeSH)</term><term>Mères (MeSH)</term><term>Nourrisson (MeSH)</term><term>Nouveau-né (MeSH)</term><term>Observance par le patient (psychologie)</term><term>Observance par le patient (statistiques et données numériques)</term><term>Population rurale (MeSH)</term><term>Transmission verticale de maladie infectieuse (prévention et contrôle)</term><term>Zimbabwe (épidémiologie)</term><term>Évaluation de programme (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-HIV Agents</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Zimbabwe</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Infectious Disease Transmission, Vertical</term><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Complications infectieuses de la grossesse</term><term>Transmission verticale de maladie infectieuse</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Complications infectieuses de la grossesse</term><term>Infections à VIH</term><term>Observance par le patient</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>HIV Infections</term><term>Patient Compliance</term><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Patient Compliance</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Observance par le patient</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Complications infectieuses de la grossesse</term><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Agents antiVIH</term><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Zimbabwe</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Cluster Analysis</term><term>Female</term><term>Humans</term><term>Infant</term><term>Infant, Newborn</term><term>Mothers</term><term>Outcome Assessment, Health Care</term><term>Pregnancy</term><term>Program Evaluation</term><term>Rural Population</term><term>Self-Help Groups</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Analyse de regroupements</term><term>Femelle</term><term>Grossesse</term><term>Groupes d'entraide</term><term>Humains</term><term>Jeune adulte</term><term>Mères</term><term>Nourrisson</term><term>Nouveau-né</term><term>Population rurale</term><term>Évaluation de programme</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Zimbabwe</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Prevention of mother-to-child transmission elimination goals are hampered by low rates of retention in care. The Eliminating Paediatric AIDS in Zimbabwe project assessed whether mother support groups (MSGs) improve rates of retention in care of HIV-exposed infants and their HIV-positive mothers, and maternal and infant outcomes.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>The study involved 27 rural clinics in eastern Zimbabwe. MSGs were established in 14 randomly selected clinics and met every 2 weeks coordinated by volunteer HIV-positive mothers. MSG coordinators provided health education and reminded mothers of MSG meetings by cell phone. Infant retention in care was defined as "12 months postpartum point attendance" at health care visits of HIV-exposed infants at 12 months of age. We also measured regularity of attendance and other program indicators of HIV-positive mothers and their HIV-exposed infants.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Among 507 HIV-positive pregnant women assessed as eligible, 348 were enrolled and analyzed (69%) with mothers who had disclosed their HIV status being overrepresented. In the intervention arm, 69% of infants were retained in care at 12 months versus 61% in the control arm, with no statistically significant difference. Retention and other program outcomes were systematically higher in the intervention versus control arm, suggesting trends toward positive health outcomes with exposure to MSGs.</p></div><div type="abstract" xml:lang="en"><p><b>DISCUSSION</b></p><p>We were unable to show that facility-based MSGs improved retention in care at 12 months among HIV-exposed infants. Selective enrollment of mothers more likely to be retained-in-care may have contributed to lack of effect. Methods to increase the impact of MSGs on retention including targeting of high-risk mothers are discussed.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28498191</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1944-7884</ISSN><JournalIssue CitedMedium="Internet"><Volume>75 Suppl 2</Volume><PubDate><Year>2017</Year><Month>06</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of acquired immune deficiency syndromes (1999)</Title><ISOAbbreviation>J Acquir Immune Defic Syndr</ISOAbbreviation></Journal><ArticleTitle>Impact of Facility-Based Mother Support Groups on Retention in Care and PMTCT Outcomes in Rural Zimbabwe: The EPAZ Cluster-Randomized Controlled Trial.</ArticleTitle><Pagination><MedlinePgn>S207-S215</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/QAI.0000000000001360</ELocationID><Abstract><AbstractText Label="BACKGROUND">Prevention of mother-to-child transmission elimination goals are hampered by low rates of retention in care. The Eliminating Paediatric AIDS in Zimbabwe project assessed whether mother support groups (MSGs) improve rates of retention in care of HIV-exposed infants and their HIV-positive mothers, and maternal and infant outcomes.</AbstractText><AbstractText Label="METHODS">The study involved 27 rural clinics in eastern Zimbabwe. MSGs were established in 14 randomly selected clinics and met every 2 weeks coordinated by volunteer HIV-positive mothers. MSG coordinators provided health education and reminded mothers of MSG meetings by cell phone. Infant retention in care was defined as "12 months postpartum point attendance" at health care visits of HIV-exposed infants at 12 months of age. We also measured regularity of attendance and other program indicators of HIV-positive mothers and their HIV-exposed infants.</AbstractText><AbstractText Label="RESULTS">Among 507 HIV-positive pregnant women assessed as eligible, 348 were enrolled and analyzed (69%) with mothers who had disclosed their HIV status being overrepresented. In the intervention arm, 69% of infants were retained in care at 12 months versus 61% in the control arm, with no statistically significant difference. Retention and other program outcomes were systematically higher in the intervention versus control arm, suggesting trends toward positive health outcomes with exposure to MSGs.</AbstractText><AbstractText Label="DISCUSSION">We were unable to show that facility-based MSGs improved retention in care at 12 months among HIV-exposed infants. Selective enrollment of mothers more likely to be retained-in-care may have contributed to lack of effect. Methods to increase the impact of MSGs on retention including targeting of high-risk mothers are discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Foster</LastName><ForeName>Geoff</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>*Ministry of Health and Child Care, Mutare, Zimbabwe; †Family AIDS Caring Trust, Mutare, Zimbabwe; ‡INSERM U1219-Centre Inserm Bordeaux Population Health, Université de Bordeaux, Bordeaux, France; §Université de Bordeaux, ISPED, Centre INSERM U1219-Bordeaux Population Health, Bordeaux, France; ‖Clinical Research Centre, Africa University, Mutare, Zimbabwe; ¶North West University, School of Basic Sciences, South Africa; #University of Zimbabwe, College of Health Sciences Harare, Zimbabwe; and **Organization for Public Health Interventions and Development, Harare, Zimbabwe.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orne-Gliemann</LastName><ForeName>Joanna</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Font</LastName><ForeName>Hélène</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Kangwende</LastName><ForeName>Abigail</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Magezi</LastName><ForeName>Vhumani</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Sengai</LastName><ForeName>Tonderai</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Rusakaniko</LastName><ForeName>Simba</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Shumba</LastName><ForeName>Bridget</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Zambezi</LastName><ForeName>Pemberai</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Maphosa</LastName><ForeName>Talent</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02216734</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Acquir Immune Defic Syndr</MedlineTA><NlmUniqueID>100892005</NlmUniqueID><ISSNLinking>1525-4135</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019380">Anti-HIV Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CitationSubset>X</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019380" MajorTopicYN="N">Anti-HIV Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018445" MajorTopicYN="N">Infectious Disease Transmission, Vertical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009035" MajorTopicYN="Y">Mothers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010349" MajorTopicYN="N">Patient Compliance</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015397" MajorTopicYN="N">Program Evaluation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012424" MajorTopicYN="N">Rural Population</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012657" MajorTopicYN="Y">Self-Help Groups</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015030" MajorTopicYN="N" Type="Geographic">Zimbabwe</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28498191</ArticleId><ArticleId IdType="doi">10.1097/QAI.0000000000001360</ArticleId><ArticleId IdType="pii">00126334-201706011-00014</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Zimbabwe</li></country><region><li>Aquitaine</li><li>Nouvelle-Aquitaine</li></region><settlement><li>Bordeaux</li></settlement><orgName><li>Université de Bordeaux</li></orgName></list><tree><noCountry><name sortKey="Font, Helene" sort="Font, Helene" uniqKey="Font H" first="Hélène" last="Font">Hélène Font</name><name sortKey="Kangwende, Abigail" sort="Kangwende, Abigail" uniqKey="Kangwende A" first="Abigail" last="Kangwende">Abigail Kangwende</name><name sortKey="Magezi, Vhumani" sort="Magezi, Vhumani" uniqKey="Magezi V" first="Vhumani" last="Magezi">Vhumani Magezi</name><name sortKey="Maphosa, Talent" sort="Maphosa, Talent" uniqKey="Maphosa T" first="Talent" last="Maphosa">Talent Maphosa</name><name sortKey="Orne Gliemann, Joanna" sort="Orne Gliemann, Joanna" uniqKey="Orne Gliemann J" first="Joanna" last="Orne-Gliemann">Joanna Orne-Gliemann</name><name sortKey="Rusakaniko, Simba" sort="Rusakaniko, Simba" uniqKey="Rusakaniko S" first="Simba" last="Rusakaniko">Simba Rusakaniko</name><name sortKey="Sengai, Tonderai" sort="Sengai, Tonderai" uniqKey="Sengai T" first="Tonderai" last="Sengai">Tonderai Sengai</name><name sortKey="Shumba, Bridget" sort="Shumba, Bridget" uniqKey="Shumba B" first="Bridget" last="Shumba">Bridget Shumba</name><name sortKey="Zambezi, Pemberai" sort="Zambezi, Pemberai" uniqKey="Zambezi P" first="Pemberai" last="Zambezi">Pemberai Zambezi</name></noCountry><country name="Zimbabwe"><region name="Nouvelle-Aquitaine"><name sortKey="Foster, Geoff" sort="Foster, Geoff" uniqKey="Foster G" first="Geoff" last="Foster">Geoff Foster</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/AutomedicationFrancoV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C05 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000C05 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= AutomedicationFrancoV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:28498191
|texte= Impact of Facility-Based Mother Support Groups on Retention in Care and PMTCT Outcomes in Rural Zimbabwe: The EPAZ Cluster-Randomized Controlled Trial.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:28498191" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AutomedicationFrancoV1
| This area was generated with Dilib version V0.6.38. |  |